Lipidomic risk score independently and cost-effectively predicts risk of future type 2 diabetes: results from diverse cohorts

[1]  Karl Claxton,et al.  Unrelated Future Costs and Unrelated Future Benefits: Reflections on NICE Guide to the Methods of Technology Appraisal. , 2016, Health economics.

[2]  Terry M. Therneau,et al.  Mixed Effects Cox Models , 2015 .

[3]  Albert Koulman,et al.  Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct case-cohort study , 2014, The lancet. Diabetes & endocrinology.

[4]  P. Meikle,et al.  Lipidomics: potential role in risk prediction and therapeutic monitoring for diabetes and cardiovascular disease. , 2014, Pharmacology & therapeutics.

[5]  P. López-Jaramillo,et al.  The role of leptin/adiponectin ratio in metabolic syndrome and diabetes , 2014, Hormone molecular biology and clinical investigation.

[6]  L. Almasy,et al.  PLASMA DIHYDROCERAMIDE SPECIES ASSOCIATE WITH WAIST CIRCUMFERENCE IN MEXICAN AMERICAN FAMILIES , 2013, Obesity.

[7]  P. Meikle,et al.  Specific plasma lipid classes and phospholipid fatty acids indicative of dairy food consumption associate with insulin sensitivity. , 2014, The American journal of clinical nutrition.

[8]  J. Shaw,et al.  Diabetes: a 21st century challenge. , 2014, The lancet. Diabetes & endocrinology.

[9]  L. Heilbronn,et al.  The effect of short‐term overfeeding on serum lipids in healthy humans , 2013, Obesity.

[10]  J. Shaw,et al.  Plasma lipid profiling in a large population-based cohort[S] , 2013, Journal of Lipid Research.

[11]  R. Vasan,et al.  2-Aminoadipic acid is a biomarker for diabetes risk. , 2013, The Journal of clinical investigation.

[12]  Adam Kowalczyk,et al.  Plasma Lipid Profiling Shows Similar Associations with Prediabetes and Type 2 Diabetes , 2013, PloS one.

[13]  L. Almasy,et al.  Plasma Lipidomic Profile Signature of Hypertension in Mexican American Families: Specific Role of Diacylglycerols , 2013, Hypertension.

[14]  Nolan J. Hoffman,et al.  Ceramide accumulation in L6 skeletal muscle cells due to increased activity of ceramide synthase isoforms has opposing effects on insulin action to those caused by palmitate treatment , 2013, Diabetologia.

[15]  Adam Oliver,et al.  A normative perspective on discounting health outcomes , 2013, Journal of health services research & policy.

[16]  Morton B. Brown,et al.  The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: An intent-to-treat analysis of the DPP/DPPOS , 2013 .

[17]  L. Almasy,et al.  Variability in Associations of Phosphatidylcholine Molecular Species with Metabolic Syndrome in Mexican–American Families , 2013, Lipids.

[18]  Morton B. Brown,et al.  Effectiveness and cost-effectiveness of diabetes prevention among adherent participants. , 2013, The American journal of managed care.

[19]  S. Hippler,et al.  Review of Models Used in Economic Analyses of New Oral Treatments for Type 2 Diabetes Mellitus , 2013, PharmacoEconomics.

[20]  Wolfgang Rathmann,et al.  The potential of novel biomarkers to improve risk prediction of type 2 diabetes , 2013, Diabetologia.

[21]  Ping Zhang,et al.  The 10-Year Cost-Effectiveness of Lifestyle Intervention or Metformin for Diabetes Prevention , 2012, Diabetes Care.

[22]  Edward A Dennis,et al.  The human plasma lipidome. , 2011, The New England journal of medicine.

[23]  I. Haviv,et al.  Plasma Lipidomic Analysis of Stable and Unstable Coronary Artery Disease , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[24]  K. Narayan,et al.  Screening for type 2 diabetes and dysglycemia. , 2011, Epidemiologic reviews.

[25]  M. Pencina,et al.  On the C‐statistics for evaluating overall adequacy of risk prediction procedures with censored survival data , 2011, Statistics in medicine.

[26]  S. Carr,et al.  Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans. , 2011, The Journal of clinical investigation.

[27]  Harald Rinde,et al.  Cost-effectiveness of risk stratification for preventing type 2 diabetes using a multi-marker diabetes risk score , 2011, Journal of medical economics.

[28]  Karl Claxton,et al.  Discounting and decision making in the economic evaluation of health-care technologies. , 2011, Health economics.

[29]  Eoin Fahy,et al.  Lipidomics reveals a remarkable diversity of lipids in human plasma1[S] , 2010, Journal of Lipid Research.

[30]  J. Nadler,et al.  Saturated- and n-6 polyunsaturated-fat diets each induce ceramide accumulation in mouse skeletal muscle: reversal and improvement of glucose tolerance by lipid metabolism inhibitors. , 2010, Endocrinology.

[31]  D. Marrero,et al.  Changes in Health State Utilities With Changes in Body Mass in the Diabetes Prevention Program , 2009, Obesity.

[32]  F. Harrell,et al.  Criteria for Evaluation of Novel Markers of Cardiovascular Risk: A Scientific Statement From the American Heart Association , 2009, Circulation.

[33]  M. Taskinen,et al.  Serum saturated fatty acids containing triacylglycerols are better markers of insulin resistance than total serum triacylglycerol concentrations , 2009, Diabetologia.

[34]  Matej Oresic,et al.  Lipidomics: a new window to biomedical frontiers. , 2008, Trends in biotechnology.

[35]  Stephen W. Sorensen,et al.  Cost-Effectiveness of Screening for Pre-Diabetes Among Overweight and Obese U.S. Adults , 2008, Diabetes Care.

[36]  J. Blangero,et al.  Genetics of variation in HOMA-IR and cardiovascular risk factors in Mexican-Americans , 2008, Journal of Molecular Medicine.

[37]  R. Nieto-Martínez,et al.  Metabolic Syndrome: From Global Epidemiology to Individualized Medicine , 2007, Clinical pharmacology and therapeutics.

[38]  Karl Claxton,et al.  Discounting and cost-effectiveness in NICE - stepping back to sort out a confusion. , 2006, Health economics.

[39]  Jing hua Zhao,et al.  Mixed-effects Cox models of alcohol dependence in extended families , 2005, BMC Genetics.

[40]  H. Sampath,et al.  The fate and intermediary metabolism of stearic acid , 2005, Lipids.

[41]  A. Futerman,et al.  LASS5 Is a Bona Fide Dihydroceramide Synthase That Selectively Utilizes Palmitoyl-CoA as Acyl Donor* , 2005, Journal of Biological Chemistry.

[42]  M. Postma,et al.  Need for differential discounting of costs and health effects in cost effectiveness analyses , 2005, BMJ : British Medical Journal.

[43]  L. Almasy,et al.  Intercellular adhesion molecule-1 concentration is genetically correlated with insulin resistance, obesity, and HDL concentration in Mexican Americans. , 2004, Diabetes.

[44]  Lisa J. Martin,et al.  The Genetics of Obesity in Mexican Americans: The Evidence from Genome Scanning Efforts in the San Antonio Family Heart Study , 2003, Human biology.

[45]  J. Real,et al.  Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism. , 2003, Diabetes care.

[46]  Ping Zhang,et al.  Costs of screening for pre-diabetes among US adults: a comparison of different screening strategies. , 2003, Diabetes care.

[47]  Within-trial cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes. , 2003, Diabetes care.

[48]  L. Almasy,et al.  Genetic Basis of Variation in Carotid Artery Plaque in the San Antonio Family Heart Study , 2002, Stroke.

[49]  J. Shaw,et al.  The Australian Diabetes, Obesity and Lifestyle Study (AusDiab)--methods and response rates. , 2002, Diabetes research and clinical practice.

[50]  S. Haffner,et al.  Identification of Persons at High Risk for Type 2 Diabetes Mellitus: Do We Need the Oral Glucose Tolerance Test? , 2002, Annals of Internal Medicine.

[51]  R. Walker,et al.  Diagnosing insulin resistance in the general population. , 2001, Diabetes care.

[52]  D A Follmann,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society Quantitative Insulin Sensitivity Check Index: A Simple, Accurate Method for Assessing Insulin Sensitivity In Humans , 2022 .

[53]  L. Almasy,et al.  Genetics of atherosclerosis risk factors in Mexican Americans. , 2009, Nutrition reviews.

[54]  L. Almasy,et al.  Multipoint quantitative-trait linkage analysis in general pedigrees. , 1998, American journal of human genetics.

[55]  S. Haffner,et al.  Insulin resistance implications for type II diabetes mellitus and coronary heart disease. , 1997, The American journal of medicine.

[56]  J. Blangero,et al.  Genetic and environmental contributions to cardiovascular risk factors in Mexican Americans. The San Antonio Family Heart Study. , 1996, Circulation.

[57]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[58]  P. Zimmet,et al.  Hyperinsulinaemia is a predictor of non-insulin-dependent diabetes mellitus. , 1991, Diabete & metabolisme.

[59]  E. DeLong,et al.  Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.

[60]  J. Hanley,et al.  The meaning and use of the area under a receiver operating characteristic (ROC) curve. , 1982, Radiology.

[61]  J A Hanley,et al.  Maximum attainable discrimination and the utilization of radiologic examinations. , 1982, Journal of chronic diseases.